Biocartis Group NV BCART-BE:Euronext Brussels

*Data is delayed | EUR
Last | 5:37 PM CEST
1.91quote price arrow down-0.05 (-2.45%)
Volume
24,654
52 week range
1.72 - 4.38
Loading...
  • Open1.99
  • Day High1.99
  • Day Low1.91
  • Prev Close1.96
  • 52 Week High4.38
  • 52 Week High Date09/02/21
  • 52 Week Low1.72
  • 52 Week Low Date03/07/22

Key Stats

  • Market Cap119.1M
  • Shares Out57.55M
  • 10 Day Average Volume70,917.36
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change-47.11

KEY STATS

  • Open1.99
  • Day High1.99
  • Day Low1.91
  • Prev Close1.96
  • 52 Week High4.38
  • 52 Week High Date09/02/21
  • 52 Week Low1.72
  • 52 Week Low Date03/07/22
  • Market Cap119.1M
  • Shares Out57.55M
  • 10 Day Average Volume70,917.36
  • Dividend-
  • Dividend Yield-
  • Beta1.51
  • YTD % Change-47.11

RATIOS/PROFITABILITY

  • EPS (TTM)-1.24
  • P/E (TTM)-1.54
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-
  • ROE (TTM)-
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Biocartis Group NV

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Biocartis Group NV is a Belgium-based company, which specializes in the development of molecular diagnostic systems, especially for the treatment of cancers and infectious diseases, the products ensure the analysis of biomolecules associated with risk factors, early detection, treatment selection and monitoring of disease. The group has the Idylla system to deliver results within a period of between 35 to 150 minutes.
Christian Reinaudo
Non-Executive Independent Chairman of the Board
Herman Verrelst
Chief Executive Officer, Executive Director
Piet Houwen
Chief Operating Officer, Representative of Scmiles BV
Jean-Marc Roelandt
Chief Financial Officer, Representative of Marcofin BV
Address
Generaal de Wittelaan 11B
Malines (mechelen)
2800
Belgium